NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00005586,Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed,https://clinicaltrials.gov/study/NCT00005586,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether chemotherapy is more effective than observation in patients who have had surgery to remove colorectal cancer.

PURPOSE: This randomized phase III trial is studying leucovorin and fluorouracil to see how well they work compared to observation in treating patients with colorectal cancer that has been surgically removed.",NO,Colorectal Cancer,DRUG: L-leucovorin|DRUG: fluorouracil|PROCEDURE: adjuvant therapy,All-cause mortality,Death from colorectal cancer|Disease recurrence,,"Institute of Cancer Research, United Kingdom",,ALL,"ADULT, OLDER_ADULT",PHASE3,2500,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,CDR0000067660|NCRI-QUASAR1|EU-99053|UKCCCR-QUASAR1|ISRCTN82375386,1997-10,,,2003-01-27,,2013-12-18,"Royal London Hospital, London, England, E1 1BB, United Kingdom",
